Corporate ActionMay 1, 2026, 04:07 PM
FibroBiologics to Sell Up to $6.15M Common Stock via ATM Offering
AI Summary
FibroBiologics, Inc. has entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, allowing the company to sell up to $6,150,000 of its common stock. The company intends to use any net proceeds from the offering for working capital and general corporate purposes. H.C. Wainwright & Co., LLC will receive a commission of 3.0% of the gross proceeds from sales, along with reimbursements for legal and due diligence-related expenses.
Key Highlights
- FibroBiologics entered an At The Market (ATM) Offering Agreement with H.C. Wainwright & Co., LLC.
- Company may sell up to $6,150,000 of common stock through the ATM offering.
- Net proceeds are expected to be used for working capital and general corporate purposes.
- Sales Agent will receive 3.0% of the gross proceeds from sales.
- Company will reimburse the Sales Agent $100,000 for legal fees.
- Company will reimburse up to $5,000 per due diligence session update for 10-K/material amendment filings.
- Company will reimburse $3,500 per due diligence update session for 10-Q filings.
Price Impact
More from FBLG